Lipocine Inc.
LPCN 1154
postpartum depression
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on LPCN 1154 for postpartum depression is expected Date TBD.
Primary source
· SEC 8-K
verified 14h ago
“Data from this Phase 3 trial are expected to support a 505(b)(2) NDA submission for LPCN 1154 in 2026.”